Skip to main content
. 2019 Jun 6;11:5301–5315. doi: 10.2147/CMAR.S202628

Table 4.

Validation of the prediction model of recurrence in TCGA

Model with clinical/copy number variation (CNV) Model with clinical/miRNA Model with clinical/miRNA/CNV
Recurrence probability scale* Cutoff=0.501 Cutoff=0.500 Cutoff=0.553
Value 95% CI Value 95% CI Value 95% CI
Sensitivity 55% 0.48, 0.61 33% 0.18, 0.47 32% 0.13, 0.52
Specificity 81% 0.65, 0.94 81% 0.77, 0.85 80% 0.75, 0.85
Positive predictive value 16% 0.07, 0.25 19% 0.12, 0.25 18% 0.08, 0.26
Negative predictive value 89% 0.87, 0.91 89% 0.88, 0.91 90% 0.87, 0.92
Accuracy 74% 0.72, 0.77 75% 0.73, 0.77 74% 0.72, 0.77

Note: *Recurrence probability scale: 1/(exp(-score)+1), where score is the resulting value of the prediction model in logit scale. As detailed in methods, the threshold was selected for specificity around 80% and highest sensitivity and negative predictive value. The goal was to create models that would rule out at least 80 of non-recurrent patients but still capturing most of patients with recurrence.